Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

Search by property

A list of all pages that have property "What are the best practices?" with value "Starting in the 18th century, more and more arguments against research with animals have been voiced. Today, guidance for ethical use of animals in research is represented by so called 3R principles. 3R stands for replacement, reduction and refinement.'"`UNIQ--ref-000000D6-QINU`"''"`UNIQ--ref-000000D7-QINU`"' Replacement implies that animals as an experimental system should be replaced with a system from which the identical conclusion could be made if it is available. Reduction means that minimal numbers of animals should be used to prove something in experiments. Refinement means that if suffering of animals is present in the experiment it should be refined with pain killing medications and other support measures. In 2013, European Union formally applied EU Directive 2010/63/EU on the protection of animals used for scientific purposes.'"`UNIQ--ref-000000D8-QINU`"'This directive refers to 3R principles, and its ultimate goal is to replace animals in research altogether. '"`UNIQ--references-000000D9-QINU`"'The application of the 3R principles is considered to be of crucial importance for the ethical use of animals in medicine testing across the European Union. Therefore, the European Medicines Agency (EMA) in collaboration with a dedicated 3Rs Working Party (3RsWP) develops scientific guidelines to help medicine developers comply with EU Directive 2010/63/EU. In order to ensure that there are no references to animal tests that are no longer considered appropriate, the EMA reviews and updates EMA guidelines to implement best practice with regard to 3Rs. Additionally, in accordance with Regulatory Science Strategy to 2025, the Agency is promoting 3Rs through a multidisciplinary group - the Innovation Task Force (ITF). This approach is expected to encourage prioritising of alternative methods and facilitate their integration into the development and evaluation of medicinal products.". Since there have been only a few results, also nearby values are displayed.

Showing below up to 2 results starting with #1.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Property: Value:

List of results

Research with animals + (Starting in the 18th century, more and mor … Starting in the 18th century, more and more arguments against research with animals have been voiced. Today, guidance for ethical use of animals in research is represented by so called 3R principles. 3R stands for replacement, reduction and refinement.'"`UNIQ--ref-000000D6-QINU`"''"`UNIQ--ref-000000D7-QINU`"' Replacement implies that animals as an experimental system should be replaced with a system from which the identical conclusion could be made if it is available. Reduction means that minimal numbers of animals should be used to prove something in experiments. Refinement means that if suffering of animals is present in the experiment it should be refined with pain killing medications and other support measures. In 2013, European Union formally applied EU Directive 2010/63/EU on the protection of animals used for scientific purposes.'"`UNIQ--ref-000000D8-QINU`"'This directive refers to 3R principles, and its ultimate goal is to replace animals in research altogether.</br>'"`UNIQ--references-000000D9-QINU`"'The application of the 3R principles is considered to be of crucial importance for the ethical use of animals in medicine testing across the European Union. Therefore, the European Medicines Agency (EMA) in collaboration with a dedicated 3Rs Working Party (3RsWP) develops scientific guidelines to help medicine developers comply with EU Directive 2010/63/EU. In order to ensure that there are no references to animal tests that are no longer considered appropriate, the EMA reviews and updates EMA guidelines to implement best practice with regard to 3Rs. Additionally, in accordance with Regulatory Science Strategy to 2025, the Agency is promoting 3Rs through a multidisciplinary group - the Innovation Task Force (ITF). This approach is expected to encourage prioritising of alternative methods and facilitate their integration into the development and evaluation of medicinal products.ment and evaluation of medicinal products.)

Research with animals +